Arturo Bravo-Nuevo

Lankenau Institute for Medical Research 
"Arturo Bravo-Nuevo"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Manley K, Bravo-Nuevo A, Minton AR, et al. (2019) Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. Journal of Cellular Biochemistry
Almonte-Baldonado R, Bravo-Nuevo A, Gerald D, et al. (2018) RhoB antibody alters retinal vascularization in models of murine retinopathy. Journal of Cellular Biochemistry
Mondal A, Smith C, DuHadaway JB, et al. (2016) IDO1 is an Integral Mediator of Inflammatory Neovascularization. Ebiomedicine
Bravo-Nuevo A, Brandli AA, Gerhart J, et al. (2015) Neuroprotective Effect of Myo/Nog Cells in the Stressed Retina. Experimental Eye Research
Bravo-Nuevo A, Marcy A, Huang M, et al. (2014) Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. Plos One. 9: e90031
Kazerounian S, Gerald D, Huang M, et al. (2013) RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Research. 73: 50-61
Bravo-Nuevo A, O'Donnell R, Rosendahl A, et al. (2011) RhoB deficiency in thymic medullary epithelium leads to early thymic atrophy. International Immunology. 23: 593-600
Bravo-Nuevo A, Sugimoto H, Iyer S, et al. (2011) RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice. The American Journal of Pathology. 178: 245-52
See more...